Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Purchases and drug use periods by ATC class among persons with Alzheimer’s disease in the MEDALZ-2005 data during years 2002-2009

From: From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)

ATC CLASS Purchases Drug use periods
N N Number of purchases per drug use period DDD of drug use period Length in days DDD per day
   Median Mean Median Sum Median Mean Median Mean
A 402,210 82,735 2 5 100 3,2475,207 150 418 0.85 1.00
B 116,233 19,422 3 6 200 7848,540 351 638 0.64 0.87
C 1,075,095 124,811 5 9 300 8,6698,771 573 864 0.60 0.78
G 130,913 21,662 3 6 133 8886,697 241 529 0.78 0.78
H 86,325 14,297 3 6 133 5062,266 253 615 0.60 0.76
J 155,495 94,577 1 2 8 2040,569 21 106 0.33 0.38
L 17,547 2,061 6 9 335 1308,533 566 778 0.80 0.81
M 202,855 70,855 1 3 33 1,0474,142 50 197 0.75 0.77
N 1,328,357 173,702 4 8 140 8,3409,222 320 596 0.68 0.75
P 3,445 1,366 1 3 6 95,713 15 217 0.40 0.42
R 117,953 29,594 1 4 64 7443,245 138 349 0.67 0.74
OTHER 156,657 68,757 1 2 0 5085,132 28 147 0.00 0.11
TOTAL 3,793,085 703,839     250,828,037     
  1. PRE2DUP created 703,839 drug use periods from 3,793,085 purchases. The total number of purchased DDDs was 250,828,037. OTHER included ATC classes D, S and V. The common names of ATC classes are found in Table 1.